Skip to player
Skip to main content
Search
Connect
Watch fullscreen
Like
Share
Bookmark
More
Add to Playlist
Report
Benzinga
Follow
Cybin ($CYBN) Exploring Psilocybin & DMT for Mental Wellness
3 years ago
Cybin is presenting data from its first-in-human trials of its proprietary psilocybin and DMT molecules for the treatment of depression and anxiety disorders during a virtual R&D day webcast on February 28th.
Category
🗞
News
Show less
Comments
Add your comment
Recommended
0:50
|
Up next
Kevin Warsh Confirmed as Next Fed Chair
Cheddar News
2 days ago
0:58
Tech’s A.I. Pivot Claims Thousands More Jobs from Major Companies
Cheddar News
2 days ago
0:51
Trump Wraps China Summit with Modest Wins
Cheddar News
2 days ago
24:18
haulover inlet boats
BoatSnaps
5 years ago
1:06
Musk OpenAI Fight
Benzinga
2 days ago
0:55
Apple OpenAI Rift
Benzinga
2 days ago
0:52
Chick-fil-A Sabbath Bias Suit
Benzinga
2 days ago
1:07
Boeing Funds Duffy Show
Benzinga
2 days ago
1:04
Ackman Buys Microsoft
Benzinga
2 days ago
1:03
LVMH Sells Marc Jacobs
Benzinga
2 days ago
1:05
Nu Revenue Hits Record
Benzinga
2 days ago
1:16
April Retail Slowdown
Benzinga
2 days ago
1:03
Raiders Stake Sale
Benzinga
2 days ago
0:58
Oil Supply Crunch Risks
Benzinga
2 days ago
1:00
Apple Mythos Exploit
Benzinga
2 days ago
0:55
Chevron Asia Asset Sale
Benzinga
2 days ago
1:19
Gemini Q1 Beat
Benzinga
2 days ago
1:00
Trump China Summit
Benzinga
2 days ago
1:08
Cerebras IPO Pops
Benzinga
2 days ago
0:59
Magnum Buyout Buzz
Benzinga
2 days ago
1:01
Virgin Slides On Q1
Benzinga
2 days ago
0:54
Automakers AI Cuts
Benzinga
2 days ago
1:09
Figma Q1 Beat
Benzinga
2 days ago
1:04
Rumble Falls On Q1
Benzinga
2 days ago
4:23
Stock Market Today: Dow Jones, S&P 500, Nasdaq Futures Decline As Trump Concludes China Visit
Benzinga
2 days ago
Comments